日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation

基于定量模型的米尔维西恩III期临床试验剂量选择研究(针对房颤患者)

Zhou, Wangda; Bozenhardt, Emily; Alexander, Gregory E; Zierhut, Matthew L; Merali, Samira; Ajavon-Hartmann, Antoinette; Zannikos, Peter; Back, Hyunmoon; Suh, EunYoung; Goyal, Navin; Samtani, Mahesh N; Plotnikov, Alexei N; Valiathan, Chandni

Esketamine Nasal Spray: Mechanism of Action, Clinical, and Translational Science

艾司氯胺酮鼻喷雾剂:作用机制、临床和转化科学

van Hoogdalem, Matthijs W; Fu, Dong-Jing; Drevets, Wayne C; Zannikos, Peter N

A Thorough QT Study to Assess the Effects of Milvexian on Cardiac Repolarization in Healthy Participants

一项全面的QT间期研究旨在评估米尔维西安对健康受试者心脏复极化的影响

Zannikos, Peter; Park, JongHanne; Dari, Anna; Takhtoukh, Samiha; Levesque, Paul; Plotnikov, Alexei N; Mitra, Amitava; Ajavon-Hartmann, Antoinette; Merali, Samira; Perez Ruixo, Juan Jose; Goyal, Navin

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Milvexian in Healthy Chinese Adults

米尔维西恩在健康中国成年人中的药代动力学、药效学、安全性和耐受性

Luo, Zhu; Wang, Jie; Niu, Zhuolu; Hu, Cuili; Chintala, Madhu; Luo, Xinchao; Lee, Tsung-I; Plotnikov, Alexei N; Zannikos, Peter

The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder

鼻内给药艾司氯胺酮对重度抑郁症或持续性抑郁症患者道路驾驶能力的影响

Dijkstra, Francis M; van de Loo, Aurora Jae; Abdulahad, Smedra; Bosma, Else R; Hartog, Mitch; Huls, Hendrikje; Kuijper, Dianne C; de Vries, Esther; Solanki, Bhavna; Singh, Jaskaran; Aluisio, Leah; Zannikos, Peter; Stuurman, Frederik E; Jacobs, Gabriël E; Verster, Joris C

Model-informed bridging of rivaroxaban doses for thromboprophylaxis in pediatric patients aged 9 years and older with congenital heart disease

基于模型指导的利伐沙班剂量桥接方案用于9岁及以上先天性心脏病患儿的血栓预防

Willmann, Stefan; Ince, Ibrahim; Ahsman, Maurice; Coboeken, Katrin; Zhang, Yang; Thelen, Kirstin; Kubitza, Dagmar; Zannikos, Peter; Zhou, Wangda; Pina, Liza Miriam; Post, Teun; Lippert, Jörg

First evaluation of tapentadol oral solution for the treatment of moderate to severe acute pain in children aged 6 to <18

首次评估他喷他多口服溶液治疗6至18岁以下儿童中度至重度急性疼痛的疗效

Finkel, Julia C; Goldberg, Jutta; Rosenburg, Ronald; Ariyawansa, Jay; Sun, Tao; Ochs-Ross, Rachel; Zannikos, Peter; Zhang, Liping; Etropolski, Mila

Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study

鼻内给予艾司氯胺酮对健康受试者认知功能的影响:一项随机、双盲、安慰剂对照研究

Morrison, Randall L; Fedgchin, Maggie; Singh, Jaskaran; Van Gerven, Joop; Zuiker, Rob; Lim, Kyoung Soo; van der Ark, Peter; Wajs, Ewa; Xi, Liwen; Zannikos, Peter; Drevets, Wayne C

Effect of trabectedin on the QT interval in patients with advanced solid tumor malignancies

曲贝替定对晚期实体瘤患者QT间期的影响

Thertulien, R; Manikhas, G M; Dirix, L Y; Vermorken, J B; Park, K; Jain, M M; Jiao, J J; Natarajan, J; Parekh, T; Zannikos, P; Staddon, A P

A phase I trial and pharmacokinetic study of a 24-hour infusion of trabectedin (Yondelis®, ET-743) in children and adolescents with relapsed or refractory solid tumors

一项针对复发或难治性实体瘤儿童和青少年的曲贝替定(Yondelis®,ET-743)24小时输注的I期试验和药代动力学研究

Chuk, Meredith K; Aikin, Alberta; Whitcomb, Trish; Widemann, Brigitte C; Zannikos, Peter; Bayever, Eliel; Balis, Frank M; Fox, Elizabeth